#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Mitochondrial encephalomyopathy Marginal zone lymphoma B-cell small lymphocytic lymphoma refractory Craniocerebral injury Non-Hodgkin's lymphoma unspecified histology indolent Diffuse large B-cell lymphoma refractory Crigler-Najjar syndrome Cholangitis sclerosing Vulval cancer Antiphospholipid antibodies Acute graft versus host disease in intestine Fabry's disease Epilepsy with myoclonic-atonic seizures B-cell small lymphocytic lymphoma recurrent Metastatic gastric cancer More trials…

    Learn about Rare Diseases

    Castleman’s disease – Life with Disease CADASIL – Trials in Disease Haemophilia A without inhibitors – Diagnostics Retinitis pigmentosa Alport’s syndrome – Treatment Wiskott-Aldrich syndrome – Trials in Disease Nodal marginal zone B-cell lymphoma – Basic Information Behcet’s syndrome – Trials in Disease Retinitis pigmentosa – Diagnostics Alternating hemiplegia of childhood – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Defactinib Sym025 XELAFASLATIDE Loperamide Hydrochloride Recombinant Interferon Beta-1B Oxaliplatin Levoleucovorin Donidalorsen Povorcitinib [68GA]GA-NOTA-AE105 7-Ethyl-10-Hydroxycamptothecin Ferric Carboxymaltose Telitacicept Esflurbiprofen Satralizumab Etifoxine Hydrochloride Gadobenate Dimeglumine Trastuzumab Tyra-300-B01 Finerenone More therapies…

    Learn about Your Condition

    Apheresis Macular degeneration Colorectal cancer stage II Haemorrhage prophylaxis Coronary artery bypass Neurodermatitis Neurodevelopmental disorder Acute hepatic failure Vulvovaginal pruritus Acute cardiac event Hepatobiliary cancer Renal impairment Staphylococcal infection Colour blindness Hypertrophic scar More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of controlled-release nicotinamide (CICR-NAM) tablets for treating mild to moderate ulcerative colitis

    Recruiting

    4 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Nicotinamide
    Germany

  • Study on Managing Locally-Advanced Rectal Cancer with Oxaliplatin, Fluorouracil, and Irinotecan Hydrochloride for Patients Responding Well to Initial Chemotherapy

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Rectal cancer
    Investigated Drugs:
    • Calcium Folinate
    • Capecitabine
    • Fluorouracil
    France

  • Study on the Effectiveness of Abemaciclib, Inavolisib, and Giredestrant in Patients with Early HR-positive/HER2-negative Breast Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Giredestrant
    • Inavolisib
    • Abemaciclib
    France Greece Italy Spain

  • Study on Oxybutynin and Venlafaxine for Reducing Hot Flashes in Women Undergoing Endocrine Therapy After Breast Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone refractory breast cancer
    • Triple positive breast cancer
    • Breast cancer
    Investigated Drugs:
    • Oxybutynin
    • Venlafaxine
    • Anastrozole
    The Netherlands

  • Study on the Safety and Effectiveness of [90Y]Y-PentixaTher in Patients with Recurrent or Resistant CNS Lymphoma

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Pentixafor
    • Pentixather
    • Gallium (68Ga)
    Germany

  • Study on the Effects of Empagliflozin for Patients with Cardiogenic Shock

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiogenic shock
    Investigated Drugs:
    • Empagliflozin
    France
Previous Page
1 … 464 465 466 467 468 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!